This finding is consistent with a very recent study showing that CXCR6 is essential for CD8+ T-cell residency in the CNS and that it acts to prevent Alzheimer’s disease pathology (45). Here, CXCR6 is linked to early-onset autosomal dominant Alzheimer disease.